Establishment Labs Holdings Inc. (NASDAQ:ESTA) stock experienced trading -40.83% off 52-week high price. On the other end, the stock has been noted 133.07% away from low price over the last 52-weeks. The stock disclosed a move of -1.77% away from 50 day moving average and -9.62% away from 200 day moving average. Moving closer, we can see that shares have been trading -5.23% off 20-day moving average. It has market cap of $407.55M.
On Sept. 25, 2020, Establishment Labs Holdings Inc. (NASDAQ:ESTA) a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, disclosed it has finalized an amendment to its distribution agreement with Puregraft LLC for Puregraft’s line of products for autologous adipose tissue harvesting and redistribution. This amended agreement, which now will continue through the end of 2022, modifies the terms of the original distribution agreement that had terminated earlier this year.
We are pleased to have reached this modified understanding with Puregraft that will enable us to continue offering the most advanced solution for fat grafting as part of our MotivaHybrid® procedure, giving women the option of a natural breast augmentation utilizing their own adipose tissue and our innovative Motiva Implants®, said chief executive officer Juan José Chacón-Quirós.
The Costa Rica based company Establishment Labs Holdings Inc. moved with change of 2.03% to $17.62 with the total traded volume of 28012 shares in recent session versus to an average volume of 40.24K. The stock was observed in the 5 days activity at -4.19%. The one month performance of stock was -5.62%. ESTA’s shares are at 3.46% for the quarter and driving a -7.07% return over the course of the past year and is now at -36.30% since this point in 2018. The average volatility for the week and month was at 8.34% and 6.42% respectively. There are 23.48M shares outstanding and 20.00M shares are floated in market.